Bowhead Specialty (NYSE:BOW) Price Target Raised to $30.00

Bowhead Specialty (NYSE:BOW) had its price objective lifted by JPMorgan Chase & Co. from $26.00 to $30.00 in a report released on Thursday morning,Benzinga reports. They currently have a neutral rating on the stock.

Several other research firms also recently commented on BOW. Keefe, Bruyette & Woods raised their price objective on shares of Bowhead Specialty from $30.00 to $33.00 and gave the stock a “market perform” rating in a report on Tuesday, October 29th. Royal Bank of Canada raised their price target on Bowhead Specialty from $32.00 to $35.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, JMP Securities increased their price objective on Bowhead Specialty from $32.00 to $33.00 and gave the stock a “market outperform” rating in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $31.40.

Bowhead Specialty Stock Up 1.0 %

Shares of BOW stock traded up $0.34 during trading hours on Thursday, hitting $32.83. 345,989 shares of the company were exchanged, compared to its average volume of 186,889. The company’s fifty day moving average price is $29.50. Bowhead Specialty has a 52-week low of $22.14 and a 52-week high of $33.85.

Bowhead Specialty (NYSE:BOW) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.38 EPS for the quarter, meeting analysts’ consensus estimates of $0.38. The firm had revenue of $116.76 million for the quarter, compared to analysts’ expectations of $113.00 million. As a group, equities analysts expect that Bowhead Specialty will post 1.3 EPS for the current year.

Insider Buying and Selling

In related news, Director Family Mutual Insuran American sold 1,362,285 shares of the business’s stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the completion of the transaction, the director now directly owns 4,700,761 shares in the company, valued at $130,211,079.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Peregrine Capital Management LLC bought a new stake in shares of Bowhead Specialty in the 2nd quarter worth approximately $3,073,000. Lighthouse Investment Partners LLC bought a new stake in Bowhead Specialty during the 2nd quarter valued at $2,653,000. Sei Investments Co. purchased a new stake in Bowhead Specialty during the 2nd quarter valued at $2,021,000. The Manufacturers Life Insurance Company purchased a new position in shares of Bowhead Specialty in the second quarter valued at about $1,458,000. Finally, Emerald Mutual Fund Advisers Trust bought a new stake in shares of Bowhead Specialty during the 2nd quarter valued at $4,901,000.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.